Dermatomyositis associated with breast cancer

Anticancer Research

Volumn 26, Issue 3 B, 2006, Pages 2329-2331

  Pectasides, Dimitrios ^a,b,c   Koumpou, Maria ^b   Gaglia, Asimina ^a,b   Pectasides, Melina ^a,b   Lambadiari, V ^a   Lianos, E ^a,b   Papaxoinis, G ^a,b   Economopoulos, Th ^a,b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b METAXA CANCER HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

Breast cancer; Dematomyositis

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CEFITINIB; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GOSERELIN; HYDROXYCHLOROQUINE; INDOMETACIN; METHOTREXATE; PACLITAXEL; PREDNISOLONE; TAMOXIFEN; TRASTUZUMAB; UNCLASSIFIED DRUG;

ADULT; ASPIRATION BIOPSY; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DERMATOMYOSITIS; DISEASE ASSOCIATION; DRUG MEGADOSE; ELECTROMYOGRAPHY; FEMALE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HUMAN; LABORATORY TEST; LYMPH NODE BIOPSY; MAMMOGRAPHY; MASTECTOMY; MUSCLE BIOPSY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REMISSION; REVIEW; RISK ASSESSMENT; SKIN BIOPSY; TREATMENT OUTCOME;

ADULT; BREAST NEOPLASMS; DERMATOMYOSITIS; FEMALE; HUMANS; MIDDLE AGED;

EID: 33745573693     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Callen JP: Myositis and malignancy. Curr Opin Rheumatol 6: 590-594, 1994.
2. Hill CL, Zhang Y et al: Frequency of specific cancer types in DM and PM. Lancet 357: 96-100, 2001.
3. Callen JP: DM and multiple malignancies in a patient treated with MTX. J Surg Oncol 24: 113-116, 1983.
4. Oddis CV and Medsger TA Jr: Rheumatology, 3rd edn. London: Mosby, 2003.
5. Bohan A and Peter JB: Polymyositis and dermatomyositis. N Engl J Med 292: 344-347, 403-407, 1975.
6. Stonecipher MR, Jorrizo JL, White WL, Walker FO and Prichard E: Cutaneous changes of DM in patients with normal muscle enzymes: DM sine myositis? J Am Acad Dermatol 28: 951-956, 1993.
7. Euwer RL and Sontheimer RD: Amyopathic DM (letter). J Am Acad Dermatol 26: 506-508, 1992.
8. Goyal S and Nousari HC: Paraneoplastic amyopathic DM associated with breast cancer recurrence. J Am Acad Dermatol 41(5 Pt 2): 874-875, 1999.
9. Verducci MA, Malkasian GD, Friedman SJ and Winkelmann RK: Gynecologic carcinoma associated with DM-PM. Obstet Gynecol 64: 695-698, 1984.
10. Sunnenberg TD and Kitchens CS: DM associated with malignant melanoma: parallel occurrence, remission, and relapse of the two processes in a patient. Cancer 51: 2157-2158, 1983.
11. Tsavaris N, Karargyris G, Pikazis D, Vadiaka M, Kosmas C, Sakellaropoulos N and Vaiopoulos G: Adenocarcinoma of the colon presenting as PM: case report. J Chemother 14: 102-105, 2002.
12. Stone OJ: DM/PM associated with internal malignancy: a consequence of how neoplasms alter generalized extracellular matrix in the host. Med Hypotheses 41: 48-51, 1993.
13. Harris AL, Smith IE and Snaith M: Tamoxifen-induced tumour regression associated with DM. Br Med J 284: 1674-1675, 1982.
14. Fudman EJ and Schnitzer TJ: DM without creatine kinase elevation: poor prognostic sign. Am J Med 80: 329-332, 1986.
15. Klippel JH and Dieppe PA: Rheumatology, 2nd edn. London: Mosby, 1998.